AR054834A1 - Derivados de 1,1-dioxido-2,3-dihidro-1,2-benzoisotiazol-6-il-1h-indazol-4-il-2,4 pirimidina diamina - Google Patents
Derivados de 1,1-dioxido-2,3-dihidro-1,2-benzoisotiazol-6-il-1h-indazol-4-il-2,4 pirimidina diaminaInfo
- Publication number
- AR054834A1 AR054834A1 ARP060103014A ARP060103014A AR054834A1 AR 054834 A1 AR054834 A1 AR 054834A1 AR P060103014 A ARP060103014 A AR P060103014A AR P060103014 A ARP060103014 A AR P060103014A AR 054834 A1 AR054834 A1 AR 054834A1
- Authority
- AR
- Argentina
- Prior art keywords
- benzoisotiazol
- dihidro
- indazol
- dioxide
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0514580A GB0514580D0 (en) | 2005-07-15 | 2005-07-15 | Novel compounds |
GB0524785A GB0524785D0 (en) | 2005-12-05 | 2005-12-05 | Novel compounds |
GB0601728A GB0601728D0 (en) | 2006-01-27 | 2006-01-27 | Novel Compounds |
GB0606763A GB0606763D0 (en) | 2006-04-03 | 2006-04-03 | Novel compounds |
GB0610513A GB0610513D0 (en) | 2006-05-26 | 2006-05-26 | Novel compounds |
GB0610924A GB0610924D0 (en) | 2006-06-02 | 2006-06-02 | Novel compounds |
GB0611488A GB0611488D0 (en) | 2006-06-09 | 2006-06-09 | Novel compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
AR054834A1 true AR054834A1 (es) | 2007-07-18 |
Family
ID=37022880
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP060103014A AR054834A1 (es) | 2005-07-15 | 2006-07-13 | Derivados de 1,1-dioxido-2,3-dihidro-1,2-benzoisotiazol-6-il-1h-indazol-4-il-2,4 pirimidina diamina |
Country Status (4)
Country | Link |
---|---|
AR (1) | AR054834A1 (fr) |
PE (1) | PE20070362A1 (fr) |
TW (1) | TW200740805A (fr) |
WO (1) | WO2007009681A1 (fr) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007085540A1 (fr) * | 2006-01-27 | 2007-08-02 | Glaxo Group Limited | Derives 1h-indaz0l-4-yl-2,4-pyrimidinediamine |
CN101796046A (zh) | 2007-07-16 | 2010-08-04 | 阿斯利康(瑞典)有限公司 | 嘧啶衍生物934 |
EP2489663A1 (fr) | 2011-02-16 | 2012-08-22 | Almirall, S.A. | Composés en tant qu'inhibiteurs de la syk kinase |
GB201104153D0 (en) * | 2011-03-11 | 2011-04-27 | Glaxo Group Ltd | Novel compounds |
US9120785B2 (en) | 2011-05-10 | 2015-09-01 | Merck Sharp & Dohme Corp. | Pyridyl aminopyridines as Syk inhibitors |
WO2012154518A1 (fr) | 2011-05-10 | 2012-11-15 | Merck Sharp & Dohme Corp. | Bipyridylaminopyridines en tant qu'inhibiteurs de syk |
CA2834604A1 (fr) | 2011-05-10 | 2012-11-15 | Merck Sharp & Dohme Corp. | Aminopyrimidines en tant qu'inhibiteurs de syk |
WO2013052394A1 (fr) | 2011-10-05 | 2013-04-11 | Merck Sharp & Dohme Corp. | Inhibiteurs de tyrosine kinase de la rate (syk) contenant un 2-pyridyl carboxamide |
EP2763975B1 (fr) | 2011-10-05 | 2016-04-06 | Merck Sharp & Dohme Corp. | Inhibiteurs de tyrosine kinase de la rate (syk) contenant un 3-pyridyl carboxamide |
WO2013052391A1 (fr) | 2011-10-05 | 2013-04-11 | Merck Sharp & Dohme Corp. | Inhibiteurs de tyrosine kinase de la rate (syk) contenant un phényl carboxamide |
WO2013192128A1 (fr) | 2012-06-20 | 2013-12-27 | Merck Sharp & Dohme Corp. | Analogues d'imidazolyle en tant qu'inhibiteurs de syk |
EP2863914B1 (fr) | 2012-06-20 | 2018-10-03 | Merck Sharp & Dohme Corp. | Dérivés de pyrazolyle en tant qu'inhibiteurs de syk |
EP2863915B1 (fr) | 2012-06-22 | 2017-12-06 | Merck Sharp & Dohme Corp. | Inhibiteurs de tyrosine kinase splénique (syk) diazines et triazines substituées |
EP2863916B1 (fr) | 2012-06-22 | 2018-07-18 | Merck Sharp & Dohme Corp. | Inhibiteurs à pyridine substituée de la tyrosine kinase de la rate (syk) |
EP2884982B1 (fr) | 2012-08-20 | 2017-09-20 | Merck Sharp & Dohme Corp. | Inhibiteurs de la phényle tyrosine kinase de la rate (syk) substitués |
WO2014048065A1 (fr) | 2012-09-28 | 2014-04-03 | Merck Sharp & Dohme Corp. | Dérivés triazolyle en tant qu'inhibiteurs de la syk |
CN103864764A (zh) * | 2012-12-11 | 2014-06-18 | 齐鲁制药有限公司 | 吲唑取代的嘧啶胺衍生物、其制备方法和用途 |
WO2014093191A1 (fr) | 2012-12-12 | 2014-06-19 | Merck Sharp & Dohme Corp. | Inhibiteurs de tyrosine kinase splénique contenant une aminopyridine |
EP2934525B1 (fr) | 2012-12-21 | 2019-05-08 | Merck Sharp & Dohme Corp. | Aminopyridines substituées par thiazole en tant qu'inhibiteurs de la tyrosine kinase de la rate |
EP2988744A4 (fr) | 2013-04-26 | 2016-11-02 | Merck Sharp & Dohme | Composés aminohétéroaryle à substitution thiazole inhibiteurs de tyrosine kinase splénique |
US9499534B2 (en) | 2013-04-26 | 2016-11-22 | Merck Sharp & Dohme Corp. | Thiazole-substituted aminopyrimidines as spleen tyrosine kinase inhibitors |
US9822107B2 (en) | 2013-12-20 | 2017-11-21 | Merck Sharp & Dohme Corp. | Thiazole-substituted aminoheteroaryls as spleen tyrosine kinase inhibitors |
EP3083560B1 (fr) | 2013-12-20 | 2021-10-27 | Merck Sharp & Dohme Corp. | Composés aminohétéroaryle à substitution thiazole utilisés comme inhibiteurs de la tyrosine kinase splénique |
WO2015094997A1 (fr) | 2013-12-20 | 2015-06-25 | Merck Sharp & Dohme Corp. | Composés aminohétéroaryle à substitution thiazole utilisés comme inhibiteurs de la tyrosine kinase splénique |
EP3116506B1 (fr) | 2014-03-13 | 2019-04-17 | Merck Sharp & Dohme Corp. | Composés 2-pyrazine carboxamide utiles comme inhibiteurs de la tyrosine kinase splénique |
AU2020242287A1 (en) | 2019-03-21 | 2021-09-02 | INSERM (Institut National de la Santé et de la Recherche Médicale) | A Dbait molecule in combination with kinase inhibitor for the treatment of cancer |
US20220401436A1 (en) | 2019-11-08 | 2022-12-22 | INSERM (Institute National de la Santé et de la Recherche Médicale) | Methods for the treatment of cancers that have acquired resistance to kinase inhibitors |
WO2021148581A1 (fr) | 2020-01-22 | 2021-07-29 | Onxeo | Nouvelle molécule dbait et son utilisation |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU1507199A (en) * | 1997-12-15 | 1999-07-05 | Yamanouchi Pharmaceutical Co., Ltd. | Novel pyrimidine-5-carboxamide derivatives |
WO2001060816A1 (fr) * | 2000-02-17 | 2001-08-23 | Amgen Inc. | Inhibiteurs de kinases |
WO2003030909A1 (fr) * | 2001-09-25 | 2003-04-17 | Bayer Pharmaceuticals Corporation | 2- et 4-aminopyrimidines n-substituees par un noyau bicyclique utilisees comme inhibiteurs de kinases dans le traitement du cancer |
TWI329105B (en) * | 2002-02-01 | 2010-08-21 | Rigel Pharmaceuticals Inc | 2,4-pyrimidinediamine compounds and their uses |
US7517886B2 (en) * | 2002-07-29 | 2009-04-14 | Rigel Pharmaceuticals, Inc. | Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds |
GB0305929D0 (en) * | 2003-03-14 | 2003-04-23 | Novartis Ag | Organic compounds |
PL1660458T3 (pl) * | 2003-08-15 | 2012-07-31 | Novartis Ag | 2,4-pirymidynodwuaminy stosowane w leczeniu chorób nowotworowych, chorób zapalnych i zaburzeń układu immunologicznego |
-
2006
- 2006-07-13 PE PE2006000835A patent/PE20070362A1/es not_active Application Discontinuation
- 2006-07-13 TW TW095125594A patent/TW200740805A/zh unknown
- 2006-07-13 WO PCT/EP2006/006953 patent/WO2007009681A1/fr active Application Filing
- 2006-07-13 AR ARP060103014A patent/AR054834A1/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
TW200740805A (en) | 2007-11-01 |
WO2007009681A1 (fr) | 2007-01-25 |
PE20070362A1 (es) | 2007-04-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR054834A1 (es) | Derivados de 1,1-dioxido-2,3-dihidro-1,2-benzoisotiazol-6-il-1h-indazol-4-il-2,4 pirimidina diamina | |
AR056691A1 (es) | Derivados pirrolopirimidina como inhibidores de syk | |
CR20110261A (es) | COMPUESTOS PIRAZOLO[1,5-a]PIRIMIDINA SUSTITUIDA COMO IHNIBIDORES DE TRK CINASA | |
PE20090835A1 (es) | Derivados de quinazolina como inhibidores de la pi3 quinasa | |
PE20120110A1 (es) | [1,2,4]triazolo[1,5-a]piridinas como inhibidores de cinasa | |
EA200901608A1 (ru) | Производные хинаксолина в качестве ингибиторов тирозинкиназной активности киназ janus | |
AR072016A1 (es) | Derivados de isoxazol que funcionan como potenciadores de los receptores de glutamato | |
CO6270288A2 (es) | Composicion fungicida que comprende cantidades significativamente efectivas de un derivadio de amida de acido carboxilico o su sal | |
PE20120034A1 (es) | Compuestos derivados de n-fenilpirimidin-2-amina | |
ATE413392T1 (de) | Kondensierte heteroyralderivate und deren verwendung als p38-kinase-inhibitoren | |
PE20120120A1 (es) | DERIVADOS DE 2H-PIRAZOLO[3,4-d]PIRIMIDINA-4,6(5H,7H)-DIONA, COMO INHIBIDORES DE PDE1 | |
PE20081346A1 (es) | Derivados de espiroindolinona como antagonistas de mdm2 | |
ATE517896T1 (de) | P38-kinase-inhibitoren | |
PE20090887A1 (es) | DERIVADOS DE 1H-PIRAZOL-[3,4-d]-PIRIMIDINA, 9H-PURINA Y 7H-PIRROL-[2,3-d]-PIRIMIDINA COMO INHIBIDORES DE CINASA P70 S6 | |
PE20120224A1 (es) | Derivados de 1h-imidazo-[4,5-c]-quinolinona | |
PE20060651A1 (es) | Compuestos de aminoheteroarilo sustituidos con pirazol como inhibidores de proteina quinasa | |
PE20121471A1 (es) | Derivados de sulfonamida heterociclicos utiles como inhibidores de mek | |
PE20141974A1 (es) | Compuestos de heterociclilo | |
DE602005009318D1 (de) | Kondensierte heteroyralderivate zur verwendung als p38-kinase-inhibitoren | |
PE20120516A1 (es) | Inhibidor de la map cinasa p38 | |
PE20141855A1 (es) | Benzotienilo-pirrolotriazinas disustituidas y sus usos | |
GT200500218A (es) | Derivados de triazolopiridinilsulfanilo como inhibidores de quinasa map p38 | |
PE20100138A1 (es) | Derivados de morfolino pirimidina usados en enfermedades relacionadas en mtor quinasa y/o pi3k | |
ECSP10010585A (es) | Compuestos de 2- imido- 3- metil pirrolo pirimidinona fenilo- sustituidos como inhibidores bace- 1, composiciones, y su uso | |
TN2009000199A1 (en) | Heteromonocyclic compound and use thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |